Runben Biotechnology Co., Ltd. (SHA:603193)

China flag China · Delayed Price · Currency is CNY
35.84
-1.19 (-3.21%)
Jun 13, 2025, 2:45 PM CST
86.28%
Market Cap 14.60B
Revenue (ttm) 1.39B
Net Income (ttm) 308.89M
Shares Out 404.59M
EPS (ttm) 0.76
PE Ratio 47.60
Forward PE 36.52
Dividend 0.46 (1.26%)
Ex-Dividend Date May 30, 2025
Volume 3,984,740
Average Volume 4,748,859
Open 36.62
Previous Close 37.03
Day's Range 35.49 - 36.99
52-Week Range 15.80 - 44.00
Beta n/a
RSI 45.83
Earnings Date Aug 15, 2025

About Runben Biotechnology

Runben Biotechnology Co., Ltd. engages in the research, production, and sale of mosquito repellent products, baby care products, and essential oil products. The company sells its products through online channels. Runben Biotechnology Co., Ltd. was founded in 2013 and is based in Guangzhou, China.Runben Biotechnology Co., Ltd. operates as a subsidiary of Guangzhou Zhuofan Investment Holding Co., Ltd [Read more]

Founded 2013
Employees 921
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603193
Full Company Profile

Financial Performance

In 2024, Runben Biotechnology's revenue was 1.32 billion, an increase of 27.61% compared to the previous year's 1.03 billion. Earnings were 300.16 million, an increase of 32.80%.

Financial Statements

News

There is no news available yet.